Familial Prion Disease with Alzheimer Disease-Like Tau Pathology and Clinical Phenotype

被引:61
|
作者
Jayadev, Suman [4 ]
Nochlin, David [5 ]
Poorkaj, Parvoneh [6 ]
Steinbart, Ellen J. [6 ]
Mastrianni, James A. [7 ]
Montine, Thomas J. [8 ]
Ghetti, Bernardino [9 ,10 ]
Schellenberg, Gerard D. [11 ]
Bird, Thomas D. [4 ,6 ,12 ]
Leverenz, James B. [1 ,2 ,3 ,4 ]
机构
[1] VA Puget Sound Hlth Care Syst, Mental Illness Clin & Educ Ctr, Seattle Div, Seattle, WA 98108 USA
[2] VA Puget Sound Hlth Care Syst, Parkinsons Dis Clin & Educ Ctr, Seattle Div, Seattle, WA 98108 USA
[3] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[4] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
[5] JFK Med Ctr, New Jersey Neurosci Inst, Edison, NJ USA
[6] VA Puget Sound Hlth Care Syst, Geriatr Res Clin & Educ Ctr, Seattle Div, Seattle, WA 98108 USA
[7] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA
[8] Univ Washington, Dept Pathol Neuropathol, Seattle, WA 98195 USA
[9] Indiana Univ Sch Med, Indiana Alzheimer Dis Ctr, Indianapolis, IN USA
[10] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN USA
[11] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[12] Univ Washington, Dept Med, Seattle, WA USA
基金
美国国家卫生研究院;
关键词
STRAUSSLER-SCHEINKER-DISEASE; CREUTZFELDT-JAKOB-DISEASE; NEUROFIBRILLARY TANGLES; AMYLOID DEPOSITS; PROTEIN; DEMENTIA; PRNP; MUTATIONS; COMPONENT; INDIANA;
D O I
10.1002/ana.22264
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To describe the Alzheimer disease (AD)-like clinical and pathological features, including marked neurofibrillary tangle (NFT) pathology, of a familial prion disease due to a rare nonsense mutation of the prion gene (PRNP). Methods: Longitudinal clinical assessments were available for the proband and her mother. After death, both underwent neuropathological evaluation. PRNP was sequenced after failure to find immunopositive A beta deposits in the proband and the documentation of prion protein (PrP) immunopositive pathology. Results: The proband presented at age 42 years with a 3-year history of progressive short-term memory impairment and depression. Neuropsychological testing found impaired memory performance, with relatively preserved attention and construction. She was diagnosed with AD and died at age 47 years. Neuropathologic evaluation revealed extensive limbic and neocortical NFT formation and neuritic plaques consistent with a Braak stage of VI. The NFTs were immunopositive, with multiple tau antibodies, and electron microscopy revealed paired helical filaments. However, the neuritic plaques were immunonegative for A beta, whereas immunostaining for PrP was positive. The mother of the proband had a similar presentation, including depression, and had been diagnosed clinically and pathologically as AD. Reevaluation of her brain tissue confirmed similar tau and PrP immunostaining findings. Genetic analysis revealed that both the proband and her mother had a rare PRNP mutation (Q160X) that resulted in the production of truncated PrP. Interpretation: We suggest that PRNP mutations that result in a truncation of PrP lead to a prolonged clinical course consistent with a clinical diagnosis of AD and severe AD-like NFTs. ANN NEUROL 2011; 69: 712-720
引用
收藏
页码:712 / 720
页数:9
相关论文
共 50 条
  • [21] Effect of aging and Alzheimer's disease-like pathology on brain monoamines in mice
    Von Linstow, C. U.
    Severino, M.
    Metaxas, A.
    Waider, J.
    Babcock, A. A.
    Lesch, K. P.
    Gramsbergen, J. B.
    Finsen, B.
    NEUROCHEMISTRY INTERNATIONAL, 2017, 108 : 238 - 245
  • [22] Mitochondria transfer as a potential therapeutic mechanism in Alzheimer's disease-like pathology
    Mishra, Mohil
    Raik, Shalini
    Rattan, Vidya
    Bhattacharyya, Shalmoli
    BRAIN RESEARCH, 2023, 1819
  • [23] Glutaminyl cyclase inhibition attenuates pyroglutamate Aβ and Alzheimer's disease-like pathology
    Schilling, Stephan
    Zeitschel, Ulrike
    Hoffmann, Torsten
    Heiser, Ulrich
    Francke, Mike
    Kehlen, Astrid
    Holzer, Max
    Hutter-Paier, Birgit
    Prokesch, Manuela
    Windisch, Manfred
    Jagla, Wolfgang
    Schlenzig, Dagmar
    Lindner, Christiane
    Rudolph, Thomas
    Reuter, Gunter
    Cynis, Holger
    Montag, Dirk
    Demuth, Hans-Ulrich
    Rossner, Steffen
    NATURE MEDICINE, 2008, 14 (10) : 1106 - 1111
  • [24] Dyrk1 inhibition improves Alzheimer's disease-like pathology
    Branca, Caterina
    Shaw, Darren M.
    Belfiore, Ramona
    Gokhale, Vijay
    Shaw, Arthur Y.
    Foley, Christopher
    Smith, Breland
    Hulme, Christopher
    Dunckley, Travis
    Meechoovet, Bessie
    Caccamo, Antonella
    Oddo, Salvatore
    AGING CELL, 2017, 16 (05) : 1146 - 1154
  • [25] Immunization with amyloid-β attenuates Alzheimer disease-like pathology in the PDAPP mouse
    Schenk, D
    Barbour, R
    Dunn, W
    Gordon, G
    Grajeda, H
    Guido, T
    Hu, K
    Huang, JP
    Johnson-Wood, K
    Khan, K
    Kholodenko, D
    Lee, M
    Liao, ZM
    Lieberburg, I
    Motter, R
    Mutter, L
    Soriano, F
    Shopp, G
    Vasquez, N
    Vandevert, C
    Walker, S
    Wogulis, M
    Yednock, T
    Games, D
    Seubert, P
    NATURE, 1999, 400 (6740) : 173 - 177
  • [26] Astrocyte Function is Modified by Alzheimer's Disease-like Pathology in Aged Mice
    Peters, Oliver
    Schipke, Carola G.
    Philipps, Andreas
    Haas, Brigitte
    Pannasch, Ulrike
    Wang, Li Ping
    Benedetti, Bruno
    Kingston, Ann E.
    Kettenmann, Helmut
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 18 (01) : 177 - 189
  • [27] CHARACTERISING THE CLINICAL PHENOTYPE OF FAMILIAL ALZHEIMER'S DISEASE (FAD)
    Ryan, N.
    Rossor, M. N.
    Fox, N. C.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2011, 82 (09):
  • [28] Ribosylation triggering Alzheimer's disease-like Tau hyperphosphorylation via activation of CaMKII
    Wei, Yan
    Han, Chanshuai
    Wang, Yujing
    Wu, Beibei
    Su, Tao
    Liu, Ying
    He, Rongqiao
    AGING CELL, 2015, 14 (05) : 754 - 763
  • [29] Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice
    Aliev, G
    Seyidova, D
    Lamb, BT
    Obrenovich, ME
    Siedlak, SL
    Vinters, HV
    Friedland, RP
    LaManna, JC
    Smith, MA
    Perry, G
    NEUROLOGICAL RESEARCH, 2003, 25 (06) : 665 - 674
  • [30] mTOR in Down syndrome: Role in Aβ and tau neuropathology and transition to Alzheimer disease-like dementia
    Di Domenico, Fabio
    Tramutola, Antonella
    Foppoli, Cesira
    Head, Elizabeth
    Perluigi, Marzia
    Butterfield, D. Allan
    FREE RADICAL BIOLOGY AND MEDICINE, 2018, 114 : 94 - 101